Artificial Intelligence is fastest growing segment fueling the growth of Shigella Vaccines market

Shigella vaccines help prevent diseases caused by Shigella bacteria. Shigellosis causes abdominal pain, fever, and diarrhea and has significantly high morbidity in developing countries. Vaccines can limit the disease's burden and spread.

The Shigella vaccines market is estimated to be valued at US$ 574.20 Mn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing demand for Shigella vaccines in developing nations is a key trend in the market. Shigellosis is more prevalent in developing countries with limited access to safe water and proper sanitation. It is estimated that 160 million cases of shigellosis occur annually, a majority in developing regions of Asia and Africa. Vaccines can help control the disease and limit its spread in high-risk populations. Another trend is the development of effective combined vaccines targeting multiple diarrheal diseases.
Segment Analysis

The global shigella vaccines market is segmented based on type, end user and distribution channel. By type, the conjugate vaccines segment currently dominates the market owing to their high immunogenicity and protections against the disease. Conjugate vaccines help mount an effective immune response against shigella infection as the saccharide antigens are covalently linked to a carrier protein.

Key Takeaways

The global shigella vaccines market is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to increasing global initiatives to control shigellosis.

Regional analysis

Regionally, the shigella vaccines market is expected to be dominated by Asia Pacific region, particularly countries like India and China. This is owing to high burden of shigellosis in these countries attributed to poor sanitation and lack of clean drinking water. In terms of growth, Latin America is anticipated to exhibit profitable opportunities for shigella vaccine manufacturers owing to rising investment by governments to reduce disease burden in the region.

Key players

Key players operating in the shigella vaccines market are MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd., Novartis (Novartis Vaccines Institute for Global Health), and GlaxoSmithKline plc. MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd's candidate, WC-rBS, is one of the leading conjugate shigella vaccines currently under development. Novartis and GSK are also developing shigella vaccine candidates to address the rising global disease burden.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more